Page results
-
The clinical management of neuromuscular muscle wasting diseases such as motor neuron disease, myasthenia gravis, muscular dystrophy and peripheral neuropathy.
-
The department provides a unique and highly specialised clinical neuropsychological diagnostic and therapeutic service for in- and outpatients.
-
The Lysholm Department of Neuroradiology is a multidisciplinary team of healthcare professionals providing leading-edge neuroradiological services, performing around 60,000 examinations and procedures per year.
-
The plasma exchange service at the National Hospital treats patients with neuroimmunological diseases such as Guillain-Barré syndrome and myasthenia gravis.
-
Information about Lutetium-177 PSMA radionuclide therapy for metastatic or treatment-resistant prostate cancer
-
The spasticity service at NHNN offers a comprehensive, responsive multidisciplinary service to adults with spasticity associated with any neurological condition.
-
We provide a specialist spinal surgery service including treatment of degenerative spinal conditions, artificial discs, spinal injury, spinal tumours (intra and extra dural, including metastatic disease), scoliosis and syringomyelia.
-
The service offers a holistic, multidisciplinary approach to the evaluation and treatment of bladder, bowel and sexual dysfunction in individuals with established and suspected neurological disorders.
-
This information has been written for patients who are having radiotherapy treatment to the brain and spine.
-
Clinical Biochemistry HSL at 60 Whitfield Street has a fully automated laboratory offering a range of routine biochemical tests to UCLH and local GPs.
File results
-
FOI/2023/0514 - Processes and software applications used in Urology
-
FOI/2023/0500 - Treatment of urothelial and colorectal cancer
-
FOI/2023/0488 - Electronic Patient Record (EPR)
-
FOI/2023/0491 - Treatment for oesophageal and gastric cancer
-
FOI/2023/0493 - Treatments for various diseases
-
FOI/2023/0497 - List of all laboratories within Pathology
-
FOI/2023/0499 - Treatments for non-small cell lung cancer
-
FOI/2023/0505 - Telecommunications infrastructure contract
-
FOI/2023/0508 - Lynch syndrome clinical pathway
-
FOI/2023/0507 - Mental health patient suicides